Sfoglia per Rivista HEMATOLOGICAL ONCOLOGY
Targeted next-generation sequencing reveals molecular heterogeneity in non-chronic lymphocytic leukemia clonal B-cell lymphocytosis
2020-01-01 Defrancesco, I.; Zibellini, S.; Boveri, E.; Frigeni, M.; Ferretti, V. V.; Rizzo, E.; Bonometti, A.; Capuano, F.; Candido, C.; Rattotti, S.; Tenore, A.; Picone, C.; Flospergher, E.; Zerbi, C.; Bergamini, F.; Fabbri, N.; Cristinelli, C.; Varettoni, M.; Paulli, M.; Arcaini, L.
Treatment of terminal-phase chronic myelogenous leukemia with intermediate-dose cytarabine and hydroxyurea
1991-01-01 Lazzarino, Mario; Morra, Enrica; Brusamolino, Ercole; Alessandrino Emilio, Paolo; Orlandi, Ester; Pagnucco, Guido; Castagnola, Carlo; Bernasconi, Paolo; Merante, Serena; Bonfichi, Maurizio; Castelli, Guglielmo; Canevari, Angelo; Bernasconi, Carlo
Tumor burden at diagnosis is the main clinical predictor of cell resistance in patients with early-stage, favorable Hodgkin lymphoma treated with VBM chemotherapy plus radiotherapy.
2012-01-01 Gobbi, Paolo; Bergonzi, Manuela; Bassi, E.; Merli, F.; Coriani, C.; Federico, M.
Tumor burden predicts treatment resistance in patients with early unfavorable or advanced-stage Hodgkin Lymphoma treated with ABVD and radiotherapy.
2012-01-01 Gobbi, Paolo; Bassi, E.; Bergonzi, E.; Merli, F.; Coriani, C.; Iannitto, E.; Luminari, S.; Polimeno, G.; Federico, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Targeted next-generation sequencing reveals molecular heterogeneity in non-chronic lymphocytic leukemia clonal B-cell lymphocytosis | 1-gen-2020 | Defrancesco, I.; Zibellini, S.; Boveri, E.; Frigeni, M.; Ferretti, V. V.; Rizzo, E.; Bonometti, A.; Capuano, F.; Candido, C.; Rattotti, S.; Tenore, A.; Picone, C.; Flospergher, E.; Zerbi, C.; Bergamini, F.; Fabbri, N.; Cristinelli, C.; Varettoni, M.; Paulli, M.; Arcaini, L. | |
| Treatment of terminal-phase chronic myelogenous leukemia with intermediate-dose cytarabine and hydroxyurea | 1-gen-1991 | Lazzarino, Mario; Morra, Enrica; Brusamolino, Ercole; Alessandrino Emilio, Paolo; Orlandi, Ester; Pagnucco, Guido; Castagnola, Carlo; Bernasconi, Paolo; Merante, Serena; Bonfichi, Maurizio; Castelli, Guglielmo; Canevari, Angelo; Bernasconi, Carlo | |
| Tumor burden at diagnosis is the main clinical predictor of cell resistance in patients with early-stage, favorable Hodgkin lymphoma treated with VBM chemotherapy plus radiotherapy. | 1-gen-2012 | Gobbi, Paolo; Bergonzi, Manuela; Bassi, E.; Merli, F.; Coriani, C.; Federico, M. | |
| Tumor burden predicts treatment resistance in patients with early unfavorable or advanced-stage Hodgkin Lymphoma treated with ABVD and radiotherapy. | 1-gen-2012 | Gobbi, Paolo; Bassi, E.; Bergonzi, E.; Merli, F.; Coriani, C.; Iannitto, E.; Luminari, S.; Polimeno, G.; Federico, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile